Extranodal Extension Predicts Poor Survival Outcomes among Patients with Bladder Cancer.

Reduced OS and CSS outcomes were observed in the pathological nodal bladder cancer patients with ENE compared with those without ENE. After the identification of pathological nodal disease, adjuvant chemotherapy was associated with better survival outcomes.